The effects of releasing early results from ongoing clinical trials
Sharing early evidence, as a trial is ongoing, is fundamental for both physicians and patients to make enrollment decisions. Here, the authors report the results of a simulation study evaluating the potential effects of early release of interim efficacy and safety data on the duration and validity o...
Main Authors: | Steffen Ventz, Sergio Bacallado, Rifaquat Rahman, Sara Tolaney, Jonathan D. Schoenfeld, Brian M. Alexander, Lorenzo Trippa |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-21116-4 |
Similar Items
-
Integration of survival data from multiple studies
by: Ventz, Steffen, et al.
Published: (2022) -
Ongoing trials in low-grade lymphoma
by: Alexander Burchardt
Published: (2011-10-01) -
Magnetic Resonance Imaging for Prediction and Assessment of Treatment Response in Bevacizumab-Treated Recurrent Glioblastoma
by: Rahman, Rifaquat M
Published: (2014) -
Early Mobilization Interventions in the Intensive Care Unit: Ongoing and Unpublished Randomized Trials
by: Janane Maheswaran, et al.
Published: (2020-01-01) -
Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials
by: Bruno Daniele, et al.
Published: (2012-06-01)